Kiniksa Pharmaceuticals International, plc
KNSANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for KNSA. That does not mean none is planned.
Get an email about KNSA's next catalysts
Track Kiniksa Pharmaceuticals International (KNSA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Rilonacept
Recurrent Pericarditis
mavrilimumab
COVID
KPL-387
Pericarditis
Vixarelimab
Prurigo Nodularis
KPL-716
Chronic Idiopathic Urticaria
prednisone
Giant Cell Arteritis
KPL-404
Arthritis, Rheumatoid
KPL-914
Recurrent Pericarditis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Rilonacept | Phase 3 | Recurrent Pericarditis | - | - |
mavrilimumab | Phase 3 | COVID | - | - |
KPL-387 | Phase 3 | Pericarditis | - | - |
Vixarelimab | Phase 2 | Prurigo Nodularis | - | - |
KPL-716 | Phase 2 | Chronic Idiopathic Urticaria | - | - |
prednisone | Phase 2 | Giant Cell Arteritis | - | - |
KPL-404 | Phase 2 | Arthritis, Rheumatoid | - | - |
KPL-914 | Phase 2 | Recurrent Pericarditis | - | - |
Frequently asked questions
What is in Kiniksa Pharmaceuticals International, plc's drug pipeline?→
CatalystAlert tracks 8 drug candidates in Kiniksa Pharmaceuticals International, plc's (KNSA) pipeline across Phase 3, Phase 2. Its lead program is KPL-387 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Kiniksa Pharmaceuticals International, plc's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Kiniksa Pharmaceuticals International, plc (KNSA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track KNSA biotech catalysts?→
Add KNSA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Kiniksa Pharmaceuticals International, plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.